Aplastic anemia history and symptoms: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:
* Increased risk of [[hemorrhage]], [[bruising]], and [[menorrhagia]] ([[thrombocytopenia]]).
* Increased risk of [[hemorrhage]], [[bruising]], and [[menorrhagia]] ([[thrombocytopenia]]).
* Increased risk of [[infection]] ([[leukopenia]])
* Increased risk of [[infection]] ([[leukopenia]])
==Diagnosis and management of aplastic anemia <ref name="pmid19038677">{{cite journal| author=Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA et al.| title=ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | journal=J Am Coll Cardiol | year= 2008 | volume= 52 | issue= 23 | pages= e1-121 | pmid=19038677 | doi=10.1016/j.jacc.2008.10.001 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19038677  }} </ref> (DONOT EDIT)==
{{cquote|
==='''[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]]'''===
'''1.''' Pregnancy in patients with ASD and severe PAH (Eisenmenger syndrome) is not recommended owing to excessive maternal and fetal mortality and should be strongly discouraged. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])
}}
'''For ACC/AHA Level of evidence and classes click [[ACC AHA Guidelines Classification Scheme|here]].'''


==References==
==References==

Revision as of 14:21, 23 September 2012

Aplastic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aplastic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aplastic anemia history and symptoms On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aplastic anemia history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aplastic anemia history and symptoms

CDC on Aplastic anemia history and symptoms

Aplastic anemia history and symptoms in the news

Blogs on Aplastic anemia history and symptoms

Directions to Hospitals Treating Aplastic anemia

Risk calculators and risk factors for Aplastic anemia history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Aplastic anemia is seen as a result of hypoplastic bone marrow causing pancytopenia (anemia, neutropenia, thrombocytopenia). The history and symptoms seen are secondary to these abnormalities.

Symptoms

Diagnosis and management of aplastic anemia [1] (DONOT EDIT)

Class III

1. Pregnancy in patients with ASD and severe PAH (Eisenmenger syndrome) is not recommended owing to excessive maternal and fetal mortality and should be strongly discouraged. (Level of Evidence: A)

For ACC/AHA Level of evidence and classes click here.

References

  1. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.